http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0d4c83402fb3a8a01e8c9c3dcfc50f9a
Outgoing Links
| Predicate | Object |
|---|---|
| family-name | Matherly |
| name | Larry H Matherly Larry H. Matherly |
| given-name | Larry H. Larry H |
| organization-name | 1Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan.; 2Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan.; 4Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan. Department of Chemical Engineering and Material Science, and Biomedical Engineering, Wayne State University, Detroit, Michigan 48202, and Cancer Biology Graduate Program, Department of Pharmacology, and Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201 Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, 110 East Warren Avenue, Detroit, Michigan 48201, United States; Cancer Biology Graduate Program, Wayne State University School of Medicine, Detroit, Michigan 48201, United States; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States; Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI;; Departments of Pharmacology and 1Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, and Departments of; 2Pharmacology, Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI; and 1Experimental and Clinical Therapeutics Program, Barbara Ann Karmanos Cancer Institute,; 3Departments of Pharmacology and Experimental and Clinical Therapeutics Program, Barbara Ann Karmanos Cancer Institute (LHM, JWT), Detroit, Michigan; The Department of Pharmacology (LHM), and the Department of Pediatrics (LHM), Wayne State University School of Medicine, and the Children's Hospital of Michigan, Detroit, Michigan From the Experimental and Clinical Therapeutics Program, Barbara Ann Karmanos Cancer Institute, the Department of Pharmacology, and the Department of Pediatrics, Wayne State University School of Medicine, the Children's Hospital of Michigan, Detroit, MI; and the Pediatric Oncology Group, Chicago, IL. 1Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute; Departments of Graduate Program in Cancer Biology, Wayne State University School of Medicine, Detroit, Michigan 48201, Division of Medicinal Chemistry, Graduate School Pharmaceutical Sciences, Duquesne University, Pittsburgh, Pennsylvania 15282, Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201, Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan 48201, and Department of Pediatrics, Children’s Hospital of Michigan, Detroit, Michigan... Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, 110 East Warren Avenue, Detroit, Michigan 48201, United States Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, USA; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, USA; Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan, USA. Electronic address: matherly@karmanos.org. Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, 110 East Warren Ave, Detroit, Michigan 48201, United States; Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States Departments of Oncology and Pharmacology Wayne State University and Karmanos Cancer Institute Detroit Michigan Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI 48201, U.S.A.; Department of Biochemistry and Molecular Biology, Wayne State University School of Medicine, Detroit, MI 48201, U.S.A.; Graduate Program in Cancer Biology, Wayne State University School of Medicine, Detroit, MI 48201, U.S.A.; Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, U.S.A. 1Department of Oncology, Wayne State University School of Medicine, and the Barbara Ann Karmanos Cancer Institute, Detroit, Michigan. Department of Oncology Wayne State University School of Medicine, Detroit, Michigan, U.S.A.; Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan, U.S.A.; Molecular Therapeutics Programme, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, U.S.A. Authors' Affiliations: 1Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute and Departments of 2Pharmacology, 3Oncology, and 4Pediatrics, Wayne State University School of Medicine; 5Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan; 6College of Life Science, Jilin University, Changchun, P.R. China; 7Beijing Institute of Transfusion Medicine, Beijing, P.R. China; and 8Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee; Authors' Affiliations: 1Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute and Departments of 2Pharmacology, 3Oncology, and 4Pediatrics, Wayne State University School of Medicine; 5Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan; 6College of Life Science, Jilin University, Changchun, P.R. China; 7Beijing Institute of Transfusion Medicine, Beijing, P.R. China; and 8Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee; Authors' Affiliations: 1Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute and Departments of 2Pharmacology, 3Oncology, and 4Pediatrics, Wayne State University School of Medicine; 5Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, Michigan; 6College of Life Science, Jilin University, Changchun, P.R. China; 7Beijing Institute of Transfusion Medicine, Beijing, P.R. China; and 8Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee From the Experimental and Clinical Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, and the Departments of Pharmacology and Pediatrics, Wayne State University School of Medicine, Detroit, MI. Experimental and Clinical Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, MI, U.S.A.; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, U.S.A.; Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI, U.S.A. Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, 110 East Warren Avenue, Detroit, Michigan 48201, United States Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, 110 East Warren Avenue, Detroit, Michigan 48201, United States; Cancer Biology Graduate Program, Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States; Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States Karmanos Cancer Institute, Wayne State University, Detroit, MI; Department of Pharmacology, Wayne State University, Detroit, MI From the Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Experimental and Clinical Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Michigan Department of Community Health, Lansing, MI, and Departments of Pediatrics and Pharmacology, Wayne State University School of Medicine, Detroit, MI. Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, 421 East Canfield Street, Detroit, Michigan 48201, United States; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States; Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, 110 East Warren Ave, Detroit, MI 48201; Graduate Program in Cancer Biology, Wayne State University School of Medicine, Detroit, Michigan 48201; Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201 1Experimental and Clinical Therapeutics Program, Barbara Ann Karmanos Cancer Institute, and the Departments of; 2Pharmacology and Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan, 48201 U.S.A.; Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan, 48201 U.S.A.; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, Michigan, 48201 U.S.A. From the Experimental and Clinical Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Institute of Environmental Health Sciences, Wayne State University, Detroit, MI; Division of Pediatric Hematology/Oncology, Children's Hospital of Michigan, Detroit, MI; Department of Pediatrics and Pharmacology, Wayne State University School of Medicine, Detroit, MI; Medical College of Virginia, Richmond, VA; University of Arkansas, Little Rock, AR; and Massachusetts General Hospital, Boston, MA. Molecular Therapeutics Program Barbara Ann Karmanos Cancer Institute Detroit Michigan USA; Department of Oncology Wayne State University School of Medicine Detroit Michigan USA; Department of Pharmacology Wayne State University School of Medicine Detroit Michigan USA Authors' Affiliation: Karmanos Cancer Institute, Wayne State University, Detroit, Michigan Department of Oncology, Wayne State University School of Medicine, Detroit, MI 48201, U.S.A.; Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI 48201, U.S.A.; Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI 48201, U.S.A. 1Karmanos Cancer Institute, Developmental Therapeutics Program and; 2Department of Pharmacology, Wayne State University School of Medicine; Departments of Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States; Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States Barbara Ann Karmanos Cancer Institute, Wayne State University School of Medicine, Detroit, Michigan 48201, USA. Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, 110 East Warren Avenue, Detroit, Michigan 48201, United States; Department of Oncology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States; Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201, United States Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI;; Departments of Pharmacology and Molecular Therapeutics Program, Barbara Ann Karmanos Cancer Institute, Detroit, MI, USA; Department of Oncology, Wayne State University School of Medicine, Detroit, MI, USA; Department of Pharmacology, Wayne State University School of Medicine, Detroit, MI, USA University of California Irvine-Long Beach Veterans Affairs Medical Program, Long Beach 90822; University of California Davis, Davis 95616; Veterans Affairs Greater Los Angeles Medical Program, University of California Los Angeles, Los Angeles, California 90073; Karmanos Cancer Institute, Detroit, Michigan 48201; and Memorial Sloan-Kettering Cancer Center, New York, New York 10021 Graduate Program in Cancer Biology, Wayne State University School of Medicine, Detroit, Michigan 48201, Division of Medicinal Chemistry, Graduate School of Pharmaceutical Sciences, Duquesne University, 600 Forbes Avenue, Pittsburgh, Pennsylvania 15282, Department of Pharmacology, Wayne State University School of Medicine, Detroit, Michigan 48201, Developmental Therapeutics Program, Barbara Ann Karmanos Cancer Institute, 110 East Warren Ave, Detroit, Michigan 48201 |
Incoming Links
Total number of triples: 190.